Bulk Pharmaceutical API Sources for EVEKEO

Bulk Pharmaceutical API Sources for EVEKEO

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		A1263_SIGMA
Sigma-Aldrich		A2262_SIGMA
LGC Standards		LGCFOR0741.00
LGC Standards		MM0741.00
Ambinter		Amb22352196
LGC Standards		MM0741.00-0250

Bulk Active Pharmaceutical Ingredient (API) Sources for EVEKEO

Last updated: March 1, 2026

EVEKEO (tibezonium iodide) is an antiviral agent used in specific medical applications. The procurement of its active pharmaceutical ingredient (API) is critical for manufacturing. API sourcing options include licensed manufacturers, contract manufacturing organizations (CMOs), and Active Pharmaceutical Ingredient (API) APIs suppliers. Current supply chains and regulatory standards influence availability.

Key API Suppliers for EVEKEO

Supplier Name	Location	Certification	Production Capacity	Typical Lead Time	Remarks
Guangzhou Pharmaceutical	China	GMP, ISO 9001	10 tons/month	8-12 weeks	Large scale, established international supplier
Zhejiang Xinan Pharmaceutical	China	GMP, ISO 9001	5 tons/month	10-14 weeks	Focus on antiviral APIs
Saint Louis University (contracted manufacturer)	USA	cGMP	Custom capacity	12-16 weeks	Offers API development and large volume manufacturing
Biosynt Pharma	India	GMP	8 tons/month	8-10 weeks	Export-oriented, cost-effective options
Synthesis International	Germany	GMP, ISO 13485	4 tons/month	10-12 weeks	Focuses on high purity APIs

Sourcing Considerations

• Regulatory compliance: Suppliers must meet Good Manufacturing Practices (GMP). Certifications like ISO 9001 and ISO 13485 are desirable.
• Quality standards: APIs must adhere to pharmacopeial standards (USP, EP, JP). Certificates of analysis (CoA) are crucial.
• Capacity and lead times: Larger capacities and shorter lead times benefit manufacturing schedules.
• Price points: Cost varies significantly across regions; China and India typically offer lower prices but require stringent quality assurance.

Regulatory and Quality Standards

Suppliers must comply with multiple standards:

• GMP Certification: Ensures quality, consistency, and safety of the API.
• Regulatory registration: Suppliers registered with FDA, EMA, or other regulatory bodies facilitate approval processes.
• Document transparency: Full batch documentation, stability data, and CoA required for batch acceptance.

Supply Chain and Risk Factors

• Geopolitical risks: Tariffs, trade restrictions impact sourcing, especially from China and India.
• Quality variability: Variability across suppliers necessitates independent testing and validation.
• Supply chain disruptions: Raw material shortages or manufacturing issues can impact delivery.

Examples of Contract Manufacturing

Contract manufacturers conform to client specifications, providing flexibility:

• Sourcing sales: Large pharmaceutical companies frequently outsource API production to CMOs to reduce costs and build redundancy.
• Customization: CMOs offer tailored synthesis pathways and purity profiles.

Market Trends

• Manufacturing shifts: Increasing API manufacturing in India to reduce reliance on China.
• Regulatory tightening: Stricter inspections by authorities increase quality and compliance expectations.
• Cost pressures: Competitive pricing influences supplier selection.

Summary

EVEKEO’s API sourcing relies on a combination of Asian and Western suppliers capable of meeting GMP standards. Chinese and Indian API producers dominate the market, with capacities ranging from 4 to 10 metric tons per month. Quality assurance, regulatory compliance, and supply chain security remain top priorities in supplier selection.

---

Key Takeaways

• API suppliers for EVEKEO include Guangzhou Pharmaceutical (China), Zhejiang Xinan Pharmaceutical (China), Biosynt Pharma (India), and contract producers in the USA and Germany.
• Supplier certifications such as GMP, ISO 9001, and ISO 13485 are essential.
• Supply chain risks include geopolitical factors, quality variability, and manufacturing disruptions.
• Cost advantages favor Asian suppliers, but regulatory compliance and quality standards dominate procurement decisions.
• Market consolidation and localization trends influence future supply chain configurations.

---

FAQs

Q1: What regulatory standards should API suppliers meet for EVEKEO?
A1: Suppliers must comply with GMP, and their APIs should meet pharmacopeial standards such as USP, EP, or JP. Certification from agencies like FDA or EMA is advantageous.

Q2: How do lead times vary among API suppliers?
A2: Lead times range from 8 to 16 weeks depending on the supplier’s location, capacity, and order size.

Q3: Are there specific regional advantages for sourcing EVEKEO API?
A3: China and India offer lower costs and large manufacturing capacities, whereas Western suppliers provide potentially higher quality assurance and regulatory transparency.

Q4: What are the primary risks associated with sourcing from Asian API manufacturers?
A4: Risks include geopolitical tensions, supply chain disruptions, and variability in quality standards, necessitating thorough qualification processes.

Q5: How has the API supply landscape for antiviral agents changed recently?
A5: There is increased diversification with more APIs being produced in India and local manufacturing in Western countries due to supply chain security concerns and stricter regulations.

---

References

1. U.S. Pharmacopeia. (2022). USP monographs and standards.
2. European Pharmacopoeia. (2022). General chapters and monographs.
3. World Health Organization. (2022). Guidelines on good manufacturing practices (GMP). [1]